Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

for
Melanoma, Lymphoma, Solid Tumor, Classical Hodgkin Lymphoma,
Location: Boston MA, New York NY, Chicago IL, Fargo ND,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT02332668

Phase 1, Phase 2, Recruiting

Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma

for
Relapsed Cancer, Refractory Multiple Myeloma, Multiple Myeloma
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT05922501

Phase 2, Recruiting

Remote Temperature Monitoring of Patients At Risk for Developing Fever

for
Fever, Cancer, Remote Patient Monitoring
Location: Schenectady NY
Sponsor: AION Biosystems

Sex: All

Age: 18+

Code: NCT06752512

Recruiting

Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06640010

Recruiting

MCW Master Predict (Profile Related Evidence Determining Individualized Cancer Therapy)

for
Cancer
Location: Milwaukee WI
Sponsor: Sameem M. Abedin, MD

Sex: All

Age: 18+

Code: NCT05802069

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Dose Escalation and Expansion Study of GIGA-564 in Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

for
Advanced or Metastatic Solid Tumor Malignancies
Location: Bethesda MD
Sponsor: GigaGen, Inc.

Sex: All

Age: 18+

Code: NCT06258304

Phase 1, Recruiting

Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18+

Code: NCT06709404

Recruiting

Connect for Cancer Prevention Study (Connect)

for
Cancer, General Research Use
Location: Detroit MI, Atlanta GA, Marshfield WI, Minneapolis MN,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 30 - 70

Code: NCT04609072

Recruiting

High Dose Re-Irradiation Utilizing Advanced Deformable Image Registration (DIR) and Individualized Organ At Risk (OAR) Dose Calculations With Organ Specific Toxicity Analysis

for
Solid Tumor
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18+

Code: NCT05301101

Recruiting

Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot Study

for
Cancer
Location: Galveston TX
Sponsor: The University of Texas Medical Branch, Galveston

Sex: All

Age: 18+

Code: NCT06098404

Recruiting

Attribution of Toxicities Due to Radiotherapy and Immuno-Biological Therapies

for
Cancer, Radiotherapy Side Effect
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT04115267

Recruiting

IDENTIFY Study: Natural History of Maternal Neoplasia

for
Maternal Neoplasia
Location: Bethesda MD
Sponsor: National Human Genome Research Institute (NHGRI)

Sex: Female

Age: 18 - 70+

Code: NCT04049604

Recruiting

Ovarian Tissue Cryopreservation in Post Pubertal (OTC-Post Pubertal)

for
Pediatric Cancer
Location: Chicago IL
Sponsor: Erin Rowell

Sex: Female

Age: 0 - 30

Code: NCT05309746

Recruiting

Informing Pain Treatment Using Pharmacogenomic Analysis

for
Adult Patients Who Are Receiving Oncologic Care
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT06511401

Recruiting

Pan-tumor MRD Study

for
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer,
Location: Shirley NY, Lancaster PA, Binghamton NY, York PA,
Sponsor: Paradigm Health

Sex: All

Age: 18+

Code: NCT06605404

Recruiting

Patient Descriptors Of Cancer-Related Fatigue: A Mixed Methods Pilot Study Of Cancer Survivors

for
Cancer, Fatigue
Location: Winston-Salem NC, Charlotte NC
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18+

Code: NCT06634381

Recruiting

TumorGlow Intraoperative Molecular Imaging (IMI)

for
Tumor, Solid
Location: Philadelphia PA
Sponsor: University of Pennsylvania

Sex: All

Age: 18+

Code: NCT04723810

Phase 1, Phase 2, Recruiting

Development and Evaluation of a Screening Approach for Sexual Dysfunction in AYA Patients With and Surviving Childhood Cancer

for
Pediatric Cancer, Survivorship
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 15 - 24

Code: NCT05524610

Recruiting

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT05098210

Phase 1, Recruiting

First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Dallas TX, Los Angeles CA
Sponsor: 1200 Pharma, LLC

Sex: All

Age: 18+

Code: NCT05103046

Phase 1, Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial